Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Genitourinary 2Thoracic 1Sarcoma 1Head & Neck 1CNS 1

Conditions

Drug-Related Side Effects and Adverse Reactions 12Lung Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 8Radiation Injuries 7Carcinoma, Ovarian Epithelial 7Carcinoma, Non-Small-Cell Lung 7Squamous Cell Carcinoma of Head and Neck 5Lymphoma, Non-Hodgkin 5Lymphoma 5Leukemia 5Hodgkin Disease 5Breast Neoplasms 5Sarcoma 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large-Cell, Immunoblastic 4Lymphoma, Large B-Cell, Diffuse 4Lymphoma, Follicular 4Lymphoma, B-Cell, Marginal Zone 4Leukemia, Myeloid, Acute 4Leukemia, Lymphocytic, Chronic, B-Cell 4Burkitt Lymphoma 4Prostatic Neoplasms 3Neurotoxicity Syndromes 3Neuroectodermal Tumors, Primitive, Peripheral 3Xerostomia 2Waldenstrom Macroglobulinemia 2Urinary Bladder Neoplasms 2Testicular Neoplasms 2

Interventions

Etoposide 22Carboplatin 22Filgrastim 17Ifosfamide 15Cisplatin 14Peripheral Blood Stem Cell Transplantation 12Paclitaxel 12Cyclophosphamide 9Bleomycin 9Thiotepa 5Radiotherapy 5Therapeutics 4Temozolomide 4Psychiatric Rehabilitation 4Oxaliplatin 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Gemcitabine 4sargramostim 3pegfilgrastim 3etoposide phosphate 3Methylprednisolone 3Dexamethasone 3Busulfan 3liposomal amphotericin B 2ixabepilone 2aldesleukin 2aflibercept 2Trastuzumab 2Topotecan 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Testicular Neoplasms × Amifostine × Clear all
NCT00003657 2017-01-20

High-dose ICE With Amifostine

Dana-Farber Cancer Institute

Phase 2 Completed
24 enrolled
CNSGenitourinaryGynecologicHead & NeckSarcomaThoracic

AIDS-related Kaposi sarcoma, Testicular Germ Cell Tumor, Squamous Cell Carcinoma of Head and Neck, Carcinoma, Ovarian Epithelial, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Chondrosarcoma, Head and Neck Neoplasms, Kidney Neoplasms, Lung Neoplasms, Neoplasms, Unknown Primary, Ovarian Neoplasms, Sarcoma, Sarcoma, Kaposi, Osteosarcoma, Testicular Neoplasms, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

NCT00003811 2013-07-04

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
27 enrolled
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡